Business
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease tests CHICAGO--(BUSINESS
About this update from Cardio Diagnostics Holdings Inc.
[{"type":"text","content":"\nresTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease tests\n\n\n CHICAGO--(BUSINESS WIRE)--\nCardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces that Houston-based resTOR Longevity Clinic will integrate Cardio Diagnostics' solutions into its battery of tests for new patients in its longevity-focused concierge clinic. This collaboration marks a significant milestone for Cardio Diagnostics, as resTOR will be the first longevity clinic in America to incorporate Cardio Diagnostics' innovative blood-based epigenetic tests for cardiovascular disease, Epi+Gen CHD and PrecisionCHD, into its testing regime for new patients.\n\n\n\"Our partnership with resTOR Longevity Clinic bridges the emerging innovative approach to medicine with a concrete application of the epigenetics of aging by using DNA methylation technologies to tackle and manage heart disease. By integrating Cardio Diagnostics' clinical tests for heart disease with a longevity-focused clinic, we are making longevity-based medicine a reality by addressing one of the leading causes of aging and death. Our ultimate goal is to partner with the most innovative provider organizations in the country and push the boundaries of modern medicine to transform innovation in cardiovascular medicine with an emphasis on living a longer and healthier life,\" stated Meesha Dogan, Ph.D., Co-Founder and CEO of Cardio Diagnostics.\n\n\nBoth organizations are focused on expanding their influence within the longevity and precision medicine fields. Cardio Diagnostics aims to continue identifying and partnering with forward-thinking clinics like resTOR Longevity to disseminate its cutting-edge technologies further. The goal is to establish a new standard in cardiovascular care that prioritizes prevention and personalized treatment plans, thereby contributing to increased patient health span and lifespan. This partnership is a stepping stone towards a broader vision where longevity-based medicine becomes the norm, and Cardio Diagnostics is at the forefront of this transformative shift.\n\n\n\"resTOR Longevity Clinic is thrilled to announce its official launch, offering a transformative approach to enhancing healthspan and lifespan,\" shared Dr. Gregory Burzynski, ...